About Ross Darwin
Form D filings for Preply from 2021 to 2022 list Ross Darwin as director.
Form D filings also name Ross Darwin as a director at Aviceda Therapeutics.
Ross Darwin first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Ross Darwin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ross Darwin works with at each company, as listed on that company's latest Form D.
Preply, Inc. · Form D, Mar 30, 2022
DV
Dmytro Voloshyn
Director
KB
Kyrylo Bigay
President and director
MG
Mariusz Gralewski
Director
RK
Robert Kniaz
Director
Aviceda Therapeutics, Inc. · Form D, Mar 28, 2022
DV
Dmytro Voloshyn
Director
RK
Robert Kniaz
Director
MG
Mariusz Gralewski
Director
KB
Kyrylo Bigay
President and director